Current Report Filing (8-k)

Date : 09/12/2019 @ 10:14AM
Source : Edgar (US Regulatory)
Stock : Amarin Corp PLC (AMRN)
Quote : 16.91  -0.57 (-3.26%) @ 4:59AM
After Hours
Last Trade
Last $ 16.75 ▼ -0.16 (-0.95%)

Current Report Filing (8-k)

AMARIN CORP PLCUK 00-0000000 false 0000897448 0000897448 2019-09-11 2019-09-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 11, 2019

 

Amarin Corporation plc

(Exact name of registrant as specified in its charter)

 

England and Wales

 

0-21392

 

Not applicable

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

     

77 Sir John Rogerson’s Quay, Block C,

Grand Canal Docklands, Dublin 2, Ireland

 

Not applicable

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: +353 1 6699 020

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) Ordinary Share of Amarin Corporation plc

 

AMRN

 

NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 8.01 Other Events

On September 11, 2019, the U.S. Food and Drug Administration (FDA) confirmed the previous tentative date, November 14, 2019, as the scheduled date for the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) meeting to review the supplemental new drug application (sNDA) related to the REDUCE-IT cardiovascular outcomes trial of Vascepa® (icosapent ethyl) capsules.

As expected, later that day, Amarin Corporation, plc received notice from the FDA that the Prescription Drug User Fee Act (PDUFA) goal date in connection with the FDA’s review of the REDUCE-IT sNDA has been extended to the date previously announced as expected, December 28, 2019. The originally assigned PDUFA date was September 28, 2019. This typical three-month extension offsets three of the four months that would have been gained from the FDA’s earlier determination to conduct a priority review of the REDUCE-IT sNDA and accommodates the time period for the EMDAC meeting. Standard 10-month review of the REDUCE-IT sNDA would have resulted in a PDUFA goal date in late January 2020.

*        *         *


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 12, 2019

 

 

Amarin Corporation plc

             

 

 

By:

 

/s/ John F. Thero

 

 

 

John F. Thero

 

 

 

President and Chief Executive Officer

Amarin (NASDAQ:AMRN)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Amarin Charts.

Amarin (NASDAQ:AMRN)
Intraday Stock Chart

Today : Tuesday 12 November 2019

Click Here for more Amarin Charts.

Latest AMRN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.